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1. Introduction 
Studies on blood-group (AtH) glycoprotein 
antigens of hog gastric mucosa have shown the 
presence of A and H determinants atthe nonreducing 
terminal ends of the branched carbohydrate chain 
[l-4] . Such oligosaccharide chains how consider- 
able variance with respect o sugar composition and 
degree of branching. Similar degree of variance, with 
respect o sugar composition and complexity of oligo- 
saccharide chains, also have been found in the blood- 
group fucolipid antigens of hog gastric mucosa [5-81. 
However, at present, all of the characterized fuco- 
lipids of this tissue carry either A or H determinants 
[7,9,101- 
During the course of studies on complex glyco- 
sphingolipids of hog gastric mucosa, obtained by a 
newly-developed xtraction procedure [11 ,121, a 
new group of fucolipids bearing (AtH) blood-group 
determinants was isolated. At least 4 types of (A+I-I)- 
active glycolipids, composed of 12 and 14 sugar 
residues, have been distinguished. We describe here 
the isolation and some of the characteristics of these 
compounds. 
2. Experimental 
2.1. Materials 
Hog stomachs used for mucosa preparation were 
purchased from Pel-Freez Biological (Rogers, AR). 
Human red cells A, B and 0 types, human blood- 
grouping serum anti-A, anti-B and anti-H (Rex 
europeus extract) were obtained from Biol. Corp. 
ElsevierfNorth-Holland Biomedical Press 
Am. (Port Reading, NJ). DEAE-Sephadex A-25 was 
from Pharmacia (Piscataway, NJ), silicic acid 
(100-200 mesh) from Bio-Rad (Richmond, CA) and 
silica gel HR plates from Analtech (Newark, DE). 
2.2. Isolation of glycolipids 
Hog gastric mucosa scrapings obtained from several 
fresh stomachs were dried with acetone, homogenized 
with 10 vol. chloroform/methanol (2/l) and filtered. 
The insoluble residue was then extracted twice, each 
time with 10 vol. 0.4 M sodium acetate in methanol/ 
chloroform/water (60/30/8), and filtered [ 1 l] . The 
combined filtrate was evaporated to dryness and 
treated with 0.2 M NaOH in methanol. After 1 h at 
37”C, the sample was taken up in an excess of.water 
and dialyzed. The nondiffusible lipids were lyophi- 
lized, dissolved in methanol/chloroform/water 
(60/30/S) and fractionated on a DEAE-Sephadex 
[ 1 l] column (2.5 X 40 cm). The crude fucolipid frac- 
tion eluted from the column with 2100 ml above 
solvent mixture was dried and acetylated with acetic 
anhydridelpyridine [ 121. Lipids recovered from the 
acetylation mixture by evaporation with toluene were 
dissolved in 1,2dichloroethane and chromatographed 
on a silicic acid column. The acetylated fucolipids, 
eluted from the column with 1,2dichloroethane/ 
acetone (l/l) and acetone, were further separated 
into individual components by thin-layer chromatog- 
raphy in 1,2dichloroethane/methanol/water (80/25/2) 
and chloroform/acetone/methanol/water (50/40/20/4). 
2.3. AnaIytical methods 
Methyl esters of fatty acids and methyl glycosides 
were obtained by methanolysis of glycolipids [141. 
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The alditol acetate derivatives of monosaccharides 
were obtained from the glycolipids according to the 
procedure in [ 151. The long-chain bases were deter- 
mined by the method in [ 161. Thin-layer chromatog- 
raphy was performed on silica gel HR plates activated 
at 130°C for 1 h. The glycolipids were visualized with 
orcinol reagent. Visualization with iodine vapors was 
used for preparative purposes. 
Gas-liquid chromatography analyses of fatty acid 
methyl esters and trimethylsilyl derivatives of methyl 
glycosides were performed on the columns (180 X 0.2 
cm) packed with 3% SE-30 on Chromosorb, W, AW, 
DMCS [ 141. Alditol acetates were analyzed on 1% 
ECNSS-M columns [141. 
Hemagglutination a d hemagglutination-inhibition 
assays were performed with the Takatsy microtitrator 
using 0.025 ml loops and a 2% suspension of human 
red cells. The anti-A and anti-B sera were diluted to 
4 units; the anti-H was commercially available at 
potency of 2 units. Isolated fucolipids prior to assay 
were deacylated with sodium methoxide [17 3 . The 
assays were performed with or without a IO-fold 
excess of auxiliary lipids [ 141. 
3. Results 
The lipids extracted from 400 g dry mucosa scrap- 
ings with sodium acetate in methanol/chloroform/ 
water, after alkaline methanolysis and DEAE-Sephadex 
column chromatography, yielded 3.9 1 g crude 
neutral glycolipids. The fucolipids present in this 
fraction were acetylated and resolved into 2 fractions 
on a silicic acid column. The fraction eluted from the 
column with 1,2-dichloroethane/acetone contained 
fucolipids I and II, whereas the acetone luate con- 
Fig.1. Thin-layer chromatogram of the acetylated blood- 
group (A+H) fucolipids purified from hog gastric mucosa. 
(1) Fucolipid I; (2) fucolipid II; (3) fucolipid III; (4) fuco- 
lipid IV. Conditions: Silica gel HR 250 nm developed in 
1,2dichloroethane/methanol/water (80/25/2). Visualization: 
orcinol reagent. 
tained fucolipids III and IV. A thin-layer chromato- 
gram of the isolated fucolipids is shown in flg.1. The 
yields of purified glycolipids I, II, III and IV were 
4.1 mg, 3.3 mg, 2.9 mg and 3.5 mg, respectively. 
Gas-liquid chromatography of the alditol acetates 
and methyl glycosides, formed from the carbohydrate 
Table 1 
Molar ratios of sphingosine and carbohydrates in the isolated fucolipids of hog gastric mucosa 
Fucolipid Molar ratiosa 
Fuc Gal Glc GlJVAc GalNAc Sphingosine 
I 2.08 5.02 1.0 3.12 1.0 0.9 
II 1.95 3.98 1.0 3.87 1.01 1.0 
III 1.92 5.78 1.0 4.05 0.92 0.9 
IV 2.05 4.92 1.0 5.01 0.95 1.1 
a Relative to Glc = 1 
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portions of the glycolipids, established the presence 
of fucose, galactose, glucose,N-acetylglucosamine 
and N-acetylgalactosamine. Themolar ratios of sugars 
and sphingosine present in the isolated fucolipids are 
given in table I. These results indicate that the oligo- 
saccharide chains of fucolipids I and II contained 
12 sugar esidues, and fucolipids III and IV, 14 sugar 
residues. Although the fucolipids I and II, and III and 
IV contained identical numbers of sugar esidues, .
they clearly differed from each other in migration 
on thin-layer plates (fig.1) and in the number of 
galactose and N-acetylglucosamine residues. Fuco- 
lipid I contained 5 galactose and 3 N-acetylglucos- 
amine residues, whereas fucolipid II contained 
4 galactose and 4 iV-acetylglucosamine residues. Six 
galactose and 4 N-acetylglucosamine residues were 
present in fucolipid III, whereas fucolipid IV con- 
tained 5 galactose and 5 N-acetylglucosamine residues. 
Apparently, these differences were sufficient o 
affect the separation of the acetylated compounds 
during thin-layer chromatography. 
In hemagglutination-inhibition assays all 4 fuco- 
lipids were potent inhibitors of agglutination of
human group A-cells by anti-A serum and human 
H-cells by anti-H lectin (Uex europeus). The extent 
of A activity of fucolipids I, II, III and IV against 
4 units of anti-A serum was 0.6,0.8, 1.1 and 1.7 pg/ 
0.1 ml, respectively, and was not significantly affected 
by the addition of auxiliary lipids. The H activity of 
fucolipids I, II, III and IV with or without auxiliary 
lipids, was 0.9, 1.0, 1.2 and 1.9 pg/O.l ml, respec- 
tively, against 2units of anti-H lectin. Thus, the 
above data clearly indicate that each of the isolated 
fucolipids bears 2 blood-group determinants, A and H. 
Analyses of the ceramide portion of the fucolipids 
revealed that shingenine was the major base of all 
4 compounds, and hexadecanoate, octadecanoate, 
octadecenoate and eicosanoate were the principal 
fatty acids. 
4. Discussion 
The occurrence of multiple forms of fucolipids 
with AEIH antigenic properties in the gastrointestinal 
tissue of mammals i well established [ 18,191. All of 
these compounds carry one type of blood-group 
determinant, which is compatible with the blood 
type of the host. Thus, the currently known fuco- 
lipids of hog gastric mucosa display either A or H 
blood-group activity [ 191. On the other hand, glyco- 
proteins of hog gastric mucosa often display both 
(A+H) blood-group activities [l-4] . The carbohydrate 
chains of these glycoproteins are highly branched and 
contain A and H determinants linked to the common 
saccharide core. A typical example of such complex 
structures are the carbohydrate chains found [3,4] in 
hog gastric mucosa blood-group (AtI-I) sulfated glyco- 
proteins, i.e., GahVAcal+3Gal(2+lcwFuc)~l+3/ 
4GlcYVAc~l+4Gal(Fuc~~l-+2Gal/3l+3/4GlcNAc~l+ 
4Gal)/W3/6Gal/3l-‘4Gl~YVAcpl-+4GlcNAc(6+SOs) 
/31+3Galpl+3GaWAc-Ser(Thr). Thefucolipids 
described here offer the first proof of the existence 
of comparable saccharide chains on the glycosphingo- 
lipids. 
The isolated fucolipids not only displayed blood- 
group (AtH) activity of a magnitude comparable to 
that of (AtI-I) active glycoproteins, but also contained 
a similar number of sugar esidues. Although the 
structures of these fucolipids remain to be determined, 
certain features of the saccharide chains can be 
suggested on the basis of immunological ssays. It is 
certain that each of the isolated fucolipids contains A 
and H antigenic determinants. Since each of these 
determinants involves one fucose residue, and there 
are 2 mol fucose/mol each glycolipid, therefore ach 
glycolipid contains one A and one H antigenic .deter- 
minant. Whether the core portion of the saccharide 
chains of the fucolipids is linear or contains additional 
branches consisting of one or more sugar esidues, 
remains to be established. In this connection, it is 
worth noting that complex fucolipids of the red-cell 
membrane [20] and hog stomach [lo] are highly 
branched. 
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